Dear Customer, If you experience any text readability or display issues on our website, please update your web browser to the latest version
.
See More
Dear Customer, If you experience any text readability or display issues on our website, please update your web browser to the latest version
.
See MoreDear Customer, If you experience any text readability or display issues on our website, please update your web browser to the latest version
.
This page has been recently translated and is available in French now.
Looks like you're visiting us from {countryName}.
Would you like to stay on the current location site or be switched to your location?
Flow cytometric analysis of vimentin in human embryonic stem (ES) cells differentiated to a neural fate. H9 human ES cells (WiCell, Madison, WI) passage 48 were differentiated with media containing Noggin (R&D Systems) for 17 days (Yuan SH, Martin J, Elia J, et al, 2011), fixed in BD Cytofix™ Fixation Buffer (Cat. No. 554655), permeabilized with BD Phosflow™ Perm buffer III (Cat. No. 558050), and stained with matching concentrations of either Alexa Fluor® 488 Mouse IgG1, κ isotype control (dashed line, Cat. No. 557721) or Alexa Fluor® 488 Mouse Anti-Vimentin monoclonal antibody (Cat. No. 562338, solid line). Histograms were derived from gated events based on light scattering characteristics of the H9-derived ectoderm. Flow cytometry was performed on a BD™ LSR II flow cytometry system.
Flow cytometric analysis of vimentin in human embryonic stem (ES) cells differentiated to a neural fate. H9 human ES cells (WiCell, Madison, WI) passage 48 were differentiated with media containing Noggin (R&D Systems) for 17 days (Yuan SH, Martin J, Elia J, et al, 2011), fixed in BD Cytofix™ Fixation Buffer (Cat. No. 554655), permeabilized with BD Phosflow™ Perm buffer III (Cat. No. 558050), and stained with matching concentrations of either Alexa Fluor® 488 Mouse IgG1, κ isotype control (dashed line, Cat. No. 557721) or Alexa Fluor® 488 Mouse Anti-Vimentin monoclonal antibody (Cat. No. 562338, solid line). Histograms were derived from gated events based on light scattering characteristics of the H9-derived ectoderm. Flow cytometry was performed on a BD™ LSR II flow cytometry system.
Immunofluorescent analysis of vimentin in mesenchymal stem cells (MSC). MSC (Lonza), passage 6, were fixed in BD Cytofix™ Fixation Buffer (Cat. No. 554655), permeabilized with 0.1% Triton™ X-100 and stained with Alexa Fluor® 488 Mouse Anti-Vimentin monoclonal antibody (Cat. No. 562338, pseudo-colored green). Counter-staining of cell nuclei was with DAPI (pseudo-colored blue). The images were captured on a BD Pathway™ 435 Cell Analyzer and merged using BD Attovision™ Software.
Flow cytometric analysis of vimentin in mesenchymal stem cells (MSC). MSC (Lonza) were fixed in BD Cytofix™ Fixation Buffer (Cat. No. 554655), permeabilized with BD Phosflow™ Perm buffer III (Cat. No. 558050), and stained with matching concentrations of either Alexa Fluor® 488 Mouse IgG1, κ isotype control (dashed line, Cat. 557721) or Alexa Fluor® 488 Mouse Anti-Vimentin monoclonal antibody (Cat. No. 562338, solid line). Histograms were derived from gated events based on light scattering characteristics of MSC. Flow cytometry was performed on a BD™ LSR II flow cytometry system.
Immunofluorescent analysis of vimentin in mesenchymal stem cells (MSC). MSC (Lonza), passage 6, were fixed in BD Cytofix™ Fixation Buffer (Cat. No. 554655), permeabilized with 0.1% Triton™ X-100 and stained with Alexa Fluor® 488 Mouse Anti-Vimentin monoclonal antibody (Cat. No. 562338, pseudo-colored green). Counter-staining of cell nuclei was with DAPI (pseudo-colored blue). The images were captured on a BD Pathway™ 435 Cell Analyzer and merged using BD Attovision™ Software.
Flow cytometric analysis of vimentin in mesenchymal stem cells (MSC). MSC (Lonza) were fixed in BD Cytofix™ Fixation Buffer (Cat. No. 554655), permeabilized with BD Phosflow™ Perm buffer III (Cat. No. 558050), and stained with matching concentrations of either Alexa Fluor® 488 Mouse IgG1, κ isotype control (dashed line, Cat. 557721) or Alexa Fluor® 488 Mouse Anti-Vimentin monoclonal antibody (Cat. No. 562338, solid line). Histograms were derived from gated events based on light scattering characteristics of MSC. Flow cytometry was performed on a BD™ LSR II flow cytometry system.
Flow cytometric analysis of vimentin in human embryonic stem (ES) cells differentiated to a neural fate. H9 human ES cells (WiCell, Madison, WI) passage 48 were differentiated with media containing Noggin (R&D Systems) for 17 days (Yuan SH, Martin J, Elia J, et al, 2011), fixed in BD Cytofix™ Fixation Buffer (Cat. No. 554655), permeabilized with BD Phosflow™ Perm buffer III (Cat. No. 558050), and stained with matching concentrations of either Alexa Fluor® 488 Mouse IgG1, κ isotype control (dashed line, Cat. No. 557721) or Alexa Fluor® 488 Mouse Anti-Vimentin monoclonal antibody (Cat. No. 562338, solid line). Histograms were derived from gated events based on light scattering characteristics of the H9-derived ectoderm. Flow cytometry was performed on a BD™ LSR II flow cytometry system.
Flow cytometric analysis of vimentin in human embryonic stem (ES) cells differentiated to a neural fate. H9 human ES cells (WiCell, Madison, WI) passage 48 were differentiated with media containing Noggin (R&D Systems) for 17 days (Yuan SH, Martin J, Elia J, et al, 2011), fixed in BD Cytofix™ Fixation Buffer (Cat. No. 554655), permeabilized with BD Phosflow™ Perm buffer III (Cat. No. 558050), and stained with matching concentrations of either Alexa Fluor® 488 Mouse IgG1, κ isotype control (dashed line, Cat. No. 557721) or Alexa Fluor® 488 Mouse Anti-Vimentin monoclonal antibody (Cat. No. 562338, solid line). Histograms were derived from gated events based on light scattering characteristics of the H9-derived ectoderm. Flow cytometry was performed on a BD™ LSR II flow cytometry system.
Immunofluorescent analysis of vimentin in mesenchymal stem cells (MSC). MSC (Lonza), passage 6, were fixed in BD Cytofix™ Fixation Buffer (Cat. No. 554655), permeabilized with 0.1% Triton™ X-100 and stained with Alexa Fluor® 488 Mouse Anti-Vimentin monoclonal antibody (Cat. No. 562338, pseudo-colored green). Counter-staining of cell nuclei was with DAPI (pseudo-colored blue). The images were captured on a BD Pathway™ 435 Cell Analyzer and merged using BD Attovision™ Software.
Flow cytometric analysis of vimentin in mesenchymal stem cells (MSC). MSC (Lonza) were fixed in BD Cytofix™ Fixation Buffer (Cat. No. 554655), permeabilized with BD Phosflow™ Perm buffer III (Cat. No. 558050), and stained with matching concentrations of either Alexa Fluor® 488 Mouse IgG1, κ isotype control (dashed line, Cat. 557721) or Alexa Fluor® 488 Mouse Anti-Vimentin monoclonal antibody (Cat. No. 562338, solid line). Histograms were derived from gated events based on light scattering characteristics of MSC. Flow cytometry was performed on a BD™ LSR II flow cytometry system.
Immunofluorescent analysis of vimentin in mesenchymal stem cells (MSC). MSC (Lonza), passage 6, were fixed in BD Cytofix™ Fixation Buffer (Cat. No. 554655), permeabilized with 0.1% Triton™ X-100 and stained with Alexa Fluor® 488 Mouse Anti-Vimentin monoclonal antibody (Cat. No. 562338, pseudo-colored green). Counter-staining of cell nuclei was with DAPI (pseudo-colored blue). The images were captured on a BD Pathway™ 435 Cell Analyzer and merged using BD Attovision™ Software.
Flow cytometric analysis of vimentin in mesenchymal stem cells (MSC). MSC (Lonza) were fixed in BD Cytofix™ Fixation Buffer (Cat. No. 554655), permeabilized with BD Phosflow™ Perm buffer III (Cat. No. 558050), and stained with matching concentrations of either Alexa Fluor® 488 Mouse IgG1, κ isotype control (dashed line, Cat. 557721) or Alexa Fluor® 488 Mouse Anti-Vimentin monoclonal antibody (Cat. No. 562338, solid line). Histograms were derived from gated events based on light scattering characteristics of MSC. Flow cytometry was performed on a BD™ LSR II flow cytometry system.
Flow cytometric analysis of vimentin in human embryonic stem (ES) cells differentiated to a neural fate. H9 human ES cells (WiCell, Madison, WI) passage 48 were differentiated with media containing Noggin (R&D Systems) for 17 days (Yuan SH, Martin J, Elia J, et al, 2011), fixed in BD Cytofix™ Fixation Buffer (Cat. No. 554655), permeabilized with BD Phosflow™ Perm buffer III (Cat. No. 558050), and stained with matching concentrations of either Alexa Fluor® 488 Mouse IgG1, κ isotype control (dashed line, Cat. No. 557721) or Alexa Fluor® 488 Mouse Anti-Vimentin monoclonal antibody (Cat. No. 562338, solid line). Histograms were derived from gated events based on light scattering characteristics of the H9-derived ectoderm. Flow cytometry was performed on a BD™ LSR II flow cytometry system.
Flow cytometric analysis of vimentin in human embryonic stem (ES) cells differentiated to a neural fate. H9 human ES cells (WiCell, Madison, WI) passage 48 were differentiated with media containing Noggin (R&D Systems) for 17 days (Yuan SH, Martin J, Elia J, et al, 2011), fixed in BD Cytofix™ Fixation Buffer (Cat. No. 554655), permeabilized with BD Phosflow™ Perm buffer III (Cat. No. 558050), and stained with matching concentrations of either Alexa Fluor® 488 Mouse IgG1, κ isotype control (dashed line, Cat. No. 557721) or Alexa Fluor® 488 Mouse Anti-Vimentin monoclonal antibody (Cat. No. 562338, solid line). Histograms were derived from gated events based on light scattering characteristics of the H9-derived ectoderm. Flow cytometry was performed on a BD™ LSR II flow cytometry system.
Immunofluorescent analysis of vimentin in mesenchymal stem cells (MSC). MSC (Lonza), passage 6, were fixed in BD Cytofix™ Fixation Buffer (Cat. No. 554655), permeabilized with 0.1% Triton™ X-100 and stained with Alexa Fluor® 488 Mouse Anti-Vimentin monoclonal antibody (Cat. No. 562338, pseudo-colored green). Counter-staining of cell nuclei was with DAPI (pseudo-colored blue). The images were captured on a BD Pathway™ 435 Cell Analyzer and merged using BD Attovision™ Software.
Flow cytometric analysis of vimentin in mesenchymal stem cells (MSC). MSC (Lonza) were fixed in BD Cytofix™ Fixation Buffer (Cat. No. 554655), permeabilized with BD Phosflow™ Perm buffer III (Cat. No. 558050), and stained with matching concentrations of either Alexa Fluor® 488 Mouse IgG1, κ isotype control (dashed line, Cat. 557721) or Alexa Fluor® 488 Mouse Anti-Vimentin monoclonal antibody (Cat. No. 562338, solid line). Histograms were derived from gated events based on light scattering characteristics of MSC. Flow cytometry was performed on a BD™ LSR II flow cytometry system.
Immunofluorescent analysis of vimentin in mesenchymal stem cells (MSC). MSC (Lonza), passage 6, were fixed in BD Cytofix™ Fixation Buffer (Cat. No. 554655), permeabilized with 0.1% Triton™ X-100 and stained with Alexa Fluor® 488 Mouse Anti-Vimentin monoclonal antibody (Cat. No. 562338, pseudo-colored green). Counter-staining of cell nuclei was with DAPI (pseudo-colored blue). The images were captured on a BD Pathway™ 435 Cell Analyzer and merged using BD Attovision™ Software.
Flow cytometric analysis of vimentin in mesenchymal stem cells (MSC). MSC (Lonza) were fixed in BD Cytofix™ Fixation Buffer (Cat. No. 554655), permeabilized with BD Phosflow™ Perm buffer III (Cat. No. 558050), and stained with matching concentrations of either Alexa Fluor® 488 Mouse IgG1, κ isotype control (dashed line, Cat. 557721) or Alexa Fluor® 488 Mouse Anti-Vimentin monoclonal antibody (Cat. No. 562338, solid line). Histograms were derived from gated events based on light scattering characteristics of MSC. Flow cytometry was performed on a BD™ LSR II flow cytometry system.
Any use of products other than the permitted use without the express written authorization of Becton, Dickinson and Company is strictly prohibited.
Intermediate filaments (IF) are a subset of cytoskeletal proteins which function to give overall structural integrity to the plasma membrane as well to organize cells into specific tissues. IF proteins can be divided into six major types based upon the similarity in sequence. Vimentin belongs to the type III category of IF proteins which are expressed in leukocytes, blood vessel endothelial cells, some epithelial cells, and mesenchymal cells. Vimentin is also expressed together with several other IF proteins during the early stages of development. Vimentin is exchanged for the tissue-specific intermediate filament type as differentiation proceeds. Vimentin migrates in SDS/PAGE as a ~57 kDa protein.
Please refer to Support Documents for Quality Certificates
Global - Refer to manufacturer's instructions for use and related User Manuals and Technical data sheets before using this products as described
Comparisons, where applicable, are made against older BD Technology, manual methods or are general performance claims. Comparisons are not made against non-BD technologies, unless otherwise noted.
Please refer to Support Documents for Quality Certificates
Global - Refer to manufacturer's instructions for use and related User Manuals and Technical data sheets before using this products as described
Comparisons, where applicable, are made against older BD Technology, manual methods or are general performance claims. Comparisons are not made against non-BD technologies, unless otherwise noted.
For Research Use Only. Not for use in diagnostic or therapeutic procedures.